Case Management

Part D patients often denied drugs for "off-label" uses

Case Management Weekly, August 8, 2007

Want to receive articles like this one in your inbox? Subscribe to Case Management Weekly!

Part D beneficiaries often cannot obtain drugs prescribed for "off-label" uses such as the treatment of pain, rare diseases and other conditions, according to a new report by the Medicare Rights Center, a nonprofit healthcare advocacy group.

 

Under rules issued last year by CMS, prescription drug plans can deny coverage for medications prescribed for "off-label" users. "Off-label" means a drug is used to treat a condition for which it is not specifically approved by the Food and Drug Administration.

 

More than 20% of prescriptions written for the 500 most commonly prescribed drugs in the U.S. are for off-label use, according the report. The most frequently denied drugs include:

  • Painkillers such as Actiq and Fentora
  • Anti-nausea drugs such as Zofran
  • Irritable bowel syndrome medications such as Lotronex

 

Source: USA Today; California Healthline



Want to receive articles like this one in your inbox? Subscribe to Case Management Weekly!

    Case Management Weekly
  • Case Management Weekly

    Case Management Weekly is a free e-mail newsletter that offers news, resources, and Q&As to help case managers from all...

  • Case Management Monthly

    This newsletter offers case studies, best practices, and how-to analysis to help case managers move patients through the...

Most Popular

Related Articles